Veterans Affairs Clinical Epidemiology Research Center, West Haven, CT, USA.
J Investig Med. 2011 Oct;59(7):1089-95. doi: 10.2310/JIM.0b013e31822bb213.
The Lambda-Mu-Sigma (LMS) method calculates the lower limit of normal for spirometric measures of pulmonary function as the fifth percentile of the distribution of z scores, suitably accounting for age-related changes in pulmonary function. Extending prior work, and to assess whether the LMS method is clinically valid when evaluating respiratory impairment in the elderly, our current objective was to evaluate the association of LMS-defined respiratory impairment (airflow limitation and restrictive pattern) with all-cause mortality and respiratory symptoms (chronic bronchitis, dyspnea, or wheezing) in older persons.
Spirometric data and outcome data on white participants aged 65 to 80 years were obtained from the Third National Health and Nutrition Examination Survey (NHANES-III, n = 1497) and the Cardiovascular Health Study (CHS, n = 3583). Multivariable analyses determined the corresponding associations, adjusting for important covariates.
In the NHANES-III and CHS populations, respectively, LMS-defined airflow limitation had adjusted hazard ratios (95% confidence interval) of 1.64 (1.28-2.11) and 1.69 (1.48-1.92) for mortality; adjusted odds ratios for respiratory symptoms were 2.71 (1.92-3.83) and 2.63 (2.11-3.27). The LMS-defined restrictive pattern was also significantly associated with mortality (adjusted hazard ratios of 1.98 [1.54-2.53] and 1.68 [1.44-1.95]), as well as with respiratory symptoms (adjusted odds ratios of 1.55 [1.03-2.34] and 1.37 [1.07-1.75]) in NHANES-III and CHS, respectively.
The LMS-defined airflow limitation and restrictive pattern confers a significantly increased risk of death and likelihood of having respiratory symptoms. These results support the use of LMS-derived spirometric z scores as a basis for evaluating respiratory impairment in older persons.
Lambda-Mu-Sigma(LMS)方法通过计算 z 分数分布的第 5 个百分位数来计算肺功能的肺活量测量的正常值下限,从而适当考虑了与年龄相关的肺功能变化。在先前工作的基础上,为了评估 LMS 方法在评估老年人呼吸障碍时的临床有效性,我们的目标是评估 LMS 定义的呼吸障碍(气流受限和限制性模式)与所有原因死亡率和老年人呼吸症状(慢性支气管炎、呼吸困难或喘息)之间的关联。
从第三次国家健康和营养检查调查(NHANES-III,n=1497)和心血管健康研究(CHS,n=3583)中获得了年龄在 65 至 80 岁的白人参与者的肺活量数据和结局数据。多变量分析确定了相应的关联,同时调整了重要的协变量。
在 NHANES-III 和 CHS 人群中,LMS 定义的气流受限分别具有死亡率的调整后的危险比(95%置信区间)1.64(1.28-2.11)和 1.69(1.48-1.92);呼吸症状的调整后比值比分别为 2.71(1.92-3.83)和 2.63(2.11-3.27)。LMS 定义的限制性模式也与死亡率显著相关(调整后的危险比为 1.98 [1.54-2.53] 和 1.68 [1.44-1.95]),以及与呼吸症状相关(调整后的比值比为 1.55 [1.03-2.34] 和 1.37 [1.07-1.75])在 NHANES-III 和 CHS 中分别。
LMS 定义的气流受限和限制性模式赋予了死亡风险显著增加和发生呼吸症状的可能性增加。这些结果支持使用 LMS 衍生的肺活量 z 分数作为评估老年人呼吸障碍的基础。